A carregar...

Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning

Abstract Background To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high doses to the cortex. In a planning study, we investig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ann-Katrin Exeli, Daniel Kellner, Lukas Exeli, Phil Steininger, Frank Wolf, Felix Sedlmayer, Heinz Deutschmann
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2018-02-01
Colecção:Radiation Oncology
Assuntos:
Acesso em linha:http://link.springer.com/article/10.1186/s13014-018-0953-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!